Archit Organosys Ltd (ARCHITORG) Share Price & Fundamentals

What we do

Archit Organosys Ltd manufactures and trades chemical products serving agrochemical, pharmaceutical, and cosmetics sectors globally.

Founded in

1,993

Market share

Established player with pan-India and international presence in specialty chemicals.

Problem solved

Supplies critical chemical intermediates and specialty chemicals for pharmaceuticals, agrochemicals, cosmetics, and oil drilling sectors.

Top clients or who we serve

Large Indian and international companies in agrochemical, pharmaceutical, and cosmetics manufacturing (B2B).

Key management

Chairman & Whole Time Director: Kandarp K. Amin; Whole Time Directors: Archana Amin, Archit Amin; CFO: Anilkumar G. Patel; Company Secretary: Chirag Chouhan.

Our journey and innovations

Founded in 1993; rebranded in 2012; expanded with manufacturing facilities in Bhavnagar (2017-18) and subsidiaries in UAE and India; introduced various chemical products such as MCA, SMCA, CAC, TCAC.

Where we operate

Operations and sales across India, USA, Europe, Latin America, Asia, and South Africa.

Top products or what we offer

Monochloroacetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloro Acetyl Chloride (CAC), TCAC, chemical intermediates for pharmaceuticals and agrochemicals.

Top brands

-

Raw materials needed

Basic chemicals used in manufacturing pharmaceutical and agrochemical intermediates.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue largely recurring through ongoing supply contracts with industrial clients.

Our industry position

Growing player with 11% revenue growth in FY25, serving niche chemical segments internationally.

Financial highlights

FY25 revenue Rs. 128.7 crore; profit before tax Rs. 7.54 crore; net profit Rs. 5.05 crore; 11.23% revenue growth YoY.

Geographical revenue split

India contributes approximately 88%, Rest of the World 12% of total revenues as of FY25.

Order book

-

Whats driving growth

Capacity expansion, product portfolio diversification, and increasing demand from pharmaceutical and agrochemical industries.

Our future plans

Focus on capacity enhancement, new product development, and expanding international market reach.

Our green promise

-

Our people and values

Committed to employee welfare, diverse and inclusive workplace, with adherence to labor laws and safety.

Key challenges ahead

Raw material price volatility, regulatory compliance, and global market competition.

Interesting facts

Has a wholly owned subsidiary in UAE and recently incorporated Archit Life Science Limited in 2023.

Risks and strategy

Mitigates risks through risk management policies, internal controls, and adherence to compliance with regular audits.